Challenges of Conducting a Feasibility Pilot Randomized Controlled Trial During COVID-19 Restrictions: Rivaroxaban Versus Acetyl Salicylic Acid in Patients with Multiple Myeloma on Lenalidomide-Based Therapy (RithMM).
Strelau M, Gal GL, McCurdy A, Shivakumar S, Wootten JC, Abouzeenni M, Phua CW, Lam S, Lazo-Langner A, Abouzeenni MY, Louzada M
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.